Archives

by in
Entry Author Date Location
With $1.3M in Seed Funding, Arcturus Adds to RNAi Hub in San Diego 06/03/13 San Diego
RNA Therapeutics Are Coming of Age 02/08/13 San Diego
San Diego’s Regulus Lowers Share Price in Revised IPO Filing 10/04/12 San Diego
Regulus Therapeutics Files for IPO as ‘Emerging Growth’ Company 08/20/12 San Diego
Biogen Idec, Regulus Cut Deal to Monitor Multiple Sclerosis 08/15/12 San Diego
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
Groove Biopharma Snags $6M to Push the Frontiers With MicroRNA Drugs 12/12/11 Seattle
The Fall of Pfizer: How Big is Too Big for Pharma Innovation? 08/29/11 National
Case Closed on Mirina vs. Marina, as Accelerator Startup Changes Name 06/22/11 Seattle
Will Biotech Ever Again Captivate the Public Imagination, Like Facebook or LinkedIn? 05/16/11 National
Regulus Names Chief Scientist 04/18/11 San Diego
Regulus, UCSD Form Alliance 04/14/11 San Diego
Ligand CEO Outlines Strategy, Arena Rebalances its Debt, Venture Biotech Versus Pharma Debate Flares Anew, & More San Diego Life Sciences News 03/31/11 San Diego
Regulus Gets License From NYU 03/30/11 San Diego
AVI Biopharma Adds Chief Scientist 03/28/11 Seattle
Q&A: UCSF’s Jeff Bluestone on the Tricky Balancing Act Between Academia and Industry 03/10/11 San Francisco
PhaseRx Angles for a Deal, Tom Clement’s New Device Gig(s), InDi’s Alzheimer’s Plan, & More in the Life Science Innovation Northwest Wrap-Up 03/04/11 Seattle
Regulus, the MicroRNA Child of Alnylam and Isis, Offers Litmus Test for Biotech Hope in 2011 02/07/11 San Diego
Some Prognostications on Biotechnology in 2011 01/07/11 San Diego
Santaris Gets $14M From Pfizer 01/04/11 San Diego
Lee Hartwell, at 70, Tackles Personalized Medicine, Education in Latest Career Phase 09/20/10 Seattle
Mirina Vs. Marina: The Looming Court Battle Over Biotech Company Names 08/16/10 Seattle
Accelerator, Taking a Break from Curing Cancer, Unwinds With Some Mini-Golf Hijinks 07/12/10 Seattle
Febit Cuts 60 Percent of Staff 06/23/10 Boston
Regulus Therapeutics, Spinoff of Isis and Alnylam, Forms $750M MicroRNA Deal With Sanofi 06/22/10 San Diego
Leroy Hood’s Personalized Medicine Vision Enters Proving Ground at Ohio State 05/18/10 Seattle
Bill Gates Backs Schrödinger, Bonanzle Lands Angel-VC Deal, Qliance Scores Big-Name Cash, & More Seattle-Area Deals News 05/04/10 Seattle
Mirina Nabs $3.9M 04/29/10 Seattle
Accelerator’s Mirina Advances, Qliance Nabs Bezos Bucks, Spiration Adds $6.5M Debt, & More Seattle-Area Life Sciences News 04/29/10 Seattle
Accelerator’s MicroRNA Play, Mirina, Forges Ahead With One More Year of Cash 04/26/10 Seattle
Page 1 of 2 next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.